Boardroom Alpha
Boardroom Alpha
SNGX · Additional Proxy Materials (DEFA14A) · Filed August 3, 2026

Soligenix Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
August 3, 2026
Ticker
SNGX
Accession
0001104659-26-089792
Boardroom Alpha · Filing insights

Soligenix, Inc. board urges voting for all five directors and charter proposals (reverse split, more shares, Say-on-Pay, adjournment).

About Soligenix Inc
Market cap
$9M
1Y TSR
−87.7%
3Y TSR
−63.6%
Board grade
C-
Sector
Healthcare
CEO
Christopher Schaber
Last annual meeting: Sep 17, 2026 · View full Soligenix Inc profile →

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934

 

Filed by the Registrant x

 

Filed by a Party other than the Registrant ¨

 

Check the appropriate box:

 

¨Preliminary Proxy Statement.

 

¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

¨Definitive Proxy Statement.

 

xDefinitive Additional Materials.

 

¨Soliciting Material Pursuant to §240.14a-12

 

SOLIGENIX, INC.

(Name of Registrant as Specified in Its Charter)

 

xNo fee required.

 

¨Fee paid previously with preliminary materials.

 

¨Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.

 

 

 

GRAPHIC

Your Vote Counts! Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # T02408-P55983 SOLIGENIX, INC. 29 EMMONS DRIVE SUITE B-10 PRINCETON, NJ 08540 SOLIGENIX, INC. 2026 Annual Meeting Vote by September 16, 2026 11:59 PM ET You invested in SOLIGENIX, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on September 17, 2026. Vote Virtually at the Meeting* September 17, 2026 9:00 a.m., Eastern Daylight Time Virtually at: www.virtualshareholdermeeting.com/SNGX2026 *Please check the meeting materials for any special requirements for meeting attendance. Get informed before you vote View the Notice and Proxy Statement and Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to September 3, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

GRAPHIC

Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends T02409-P55983 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. 1. To elect five directors to serve until the next Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified. For All Nominees: 01) Christopher J. Schaber, Ph.D. 02) Gregg A. Lapointe, C.P.A. 03) Diane L. Parks, M.B.A. 04) Robert J. Rubin, M.D. 05) Jerome B. Zeldis, M.D., Ph.D. 2. To approve an amendment to our Second Amended and Restated Certificate of Incorporation, to, at the discretion of the Board of Directors exercisable for a period of up to one year, effect a reverse stock split with respect to the issued and outstanding common stock at a ratio of 1-for-2 to 1-for-20, with the ratio to be determined at the discretion of the Board of Directors and included in a public announcement. For 3. To approve an amendment to our Second Amended and Restated Certificate of Incorporation, to increase the number of authorized shares of common stock from 75,000,000 to 125,000,000. For 4. To hold an advisory vote on executive compensation. For 5. To hold an advisory vote on the frequency of holding an advisory vote on executive compensation. 1 Year 6. To ratify the appointment of Cherry Bekaert LLP as our independent registered public accounting firm for the year ending December 31, 2026. For 7. To approve an adjournment of the Annual Meeting, in whole or in part as to any particular proposal(s), to a later date or dates, if necessary, to permit further solicitation of proxies in the event there are not sufficient shares voted to constitute a quorum or votes in favor of a particular proposal for approval. For Note: To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Soligenix Inc (SNGX)

Reference

Frequently asked questions

When did Soligenix Inc file this DEFA14A?
Soligenix Inc (SNGX) filed this Additional Proxy Materials (DEFA14A) with the SEC on August 3, 2026. The accession number assigned by EDGAR is 0001104659-26-089792.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Soligenix, Inc. board urges voting for all five directors and charter proposals (reverse split, more shares, Say-on-Pay, adjournment). This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Soligenix Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Soligenix Inc has filed under CIK 812796, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer